Long-term effect of ileogastrostomy surgery for morbid obesity on diabetes mellitus and sleep apnea

Obesity Surgery

Volumn 16, Issue 10, 2006, Pages 1337-1341

  Cleator, Iain G M ^a,b   Birmingham, Carl Laird ^a   Kovacevic, Senka ^a   Cleator, Maria M ^a   Gritzner, Susan ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Cleator Clinic   (Canada)

Author keywords

Diabetes mellitus; Ileogastrostomy; Incretin; Morbid obesity; Obesity surgery; Sleep apnea

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GASTROSTOMY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REGISTER; REMISSION; SLEEP APNEA SYNDROME;

ADULT; BODY MASS INDEX; COMORBIDITY; DIABETES MELLITUS; FEMALE; GASTROSTOMY; HUMANS; ILEOSTOMY; JEJUNOILEAL BYPASS; MALE; MIDDLE AGED; OBESITY, MORBID; SLEEP APNEA SYNDROMES; TREATMENT OUTCOME;

EID: 33750560424     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089206778663850     Document Type: Article

References (30)

1. Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339-50; discussion 50-2.
2. Scopinaro N, Adami GF, Marinari GM et al. Biliopancreatic diversion. World J Surg 1998; 22: 936-46.
3. Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 2002; 236: 554-9.
4. Cleator IG, Gourlay RH. Ileogastrostomy for morbid obesity. Can J Surg 1988; 31: 114-6.
5. Cleator IG, Litwin D, Phang P et al. Laparoscopic ileogastrostomy for morbid obesity. Obes Surg 1994; 4: 358-60.
6. Cleator IG, Litwin DE, Phang PT et al. Laparoscopic ileogastrostomy. Obes Surg 1994; 4: 40-3.
7. Cleator IG, Polyakov G, Birmingham CL. Ileogastrostomy or jejunoileal bypass with drainage of the bypassed bowel into the stomach. Eur J Gastroenterol Hepatol 1999; 11: 85-8.
8. Cleator IG, Rae AJ, Birmingham CL. Helicobacter pylori-induced diarrhea post-ileogastrostomy. Obes Surg 1994; 4: 293-6.
9. Cleator II, Holden J, Brosseuk D et al. Liver biopsies following ileogastrostomy. Obes Surg 1993; 3: 253-5.
10. Dingee CK, Cleator IG, MacFarlane JK et al. Follow-up of patients who have undergone ileogastrostomy. Can J Surg 1990; 33: 25-7.
11. Rae AJ, Cleator IG. Quality of life assessment, of ileogastrostomy. Obes Surg 1993; 3: 360-4.
12. Mokdad AH, Bowman BA, Ford ES et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 1195-200.
13. Brown DF, Jackson TW. Diabetes: 'tight control' in a comprehensive treatment plan. Geriatrics 1994; 49: 24-9.
14. Livingston EH, Ko CY. Effect of diabetes and hypertension on obesity-related mortality. Surgery 2005; 137: 16-25.
15. Kannel WB, Wilson PW, Zhang, TJ. The epidemiology of impaired glucose tolerance and hypertension. Am Heart J 1991; 121: 268-73.
16. Herbst CA, Hughes TA, Gwynne JT et al. Gastric bariatric operation in insulin-treated adults. Surgery 1984; 95: 209-14.
17. Scopinaro N, Marinari GM, Camerini GB et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care 2005; 28: 2406-11.
18. Koenig SM. Pulmonary complications of obesity. Am J Med Sci 2001; 321: 249-79.
19. Odens ML, Fox CH. Adult sleep apnea syndromes. Am Fam Phys 1995; 52: 859-66.
20. Partinen M, Guilleminault C. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest 1990; 97: 27-32.
21. Pillar G, Peled R, Lavie P. Recurrence of sleep apnea without concomitant weight increase 7.5 years after weight reduction surgery. Chest 1994; 106: 1702-4.
22. Mason EE, Tang S, Renquist KE et al. A decade of change in obesity surgery. National Bariatric Surgery Registry (NBSR) Contributors. Obes Surg 1997; 7: 189-97.
23. Brown JC, Cleator IG, Dryburgh JR et al. The physiology and pathophysiology of gastric inhibitory polypeptide (GIP) and motilin. Verh Dtsch Ges Inn Med 1974; 80: 377-80.
24. Cleator IG, Gourlay RH. Release of immunoreactive gastric inhibitory polypeptide (IR-GIP) by oral ingestion of food substances. Am J Surg 1975; 130: 128-35.
25. Dooner J, Burget D, Cleator, IG. Glucose handling in morbid obesity and the effects of surgically induced weight loss. JPEN 1984; 8: 660-4.
26. Valverde I, Puente J, Martin-Duce A et al. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects. Obes Surg 2005; 15: 387-97.
27. Mason EE. The mechanisms of surgical treatment of type 2 diabetes (Editorial). Obes Surg 2005; 15: 459-61.
28. Patriti A, Facchiano E, Annetti C et al. Early improvment of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg 2005; 15: 1258-64.
29. Damholt AB, Buchan AM, Kofod H. Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose. Endocrinology 1998; 139: 2085-91.
30. Naslund E, Backman L, Holst JJ et al. Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg 1998; 8: 253-60.